Skip to main content
. 2023 Feb 20;15(2):709. doi: 10.3390/pharmaceutics15020709

Figure 8.

Figure 8

In vitro drug-release study of optimized formulation (OP1 and OP2) in comparison with pure TEL using simulated gastric fluid (pH 1.2) as dissolution medium.